Lattulosio Abc

Lactulose, the active ingredient in Lattulosio Abc, is an osmotic laxative presented as an oral formulation for oral use. It is used to relieve constipation and to reduce ammonia levels in patients with hepatic encephalopathy, primarily in adult populations.

GNH USA supplies Lattulosio Abc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to essential medicines across multiple markets and ensuring compliance with regulatory standards.

Lactulose is an osmotic laxative used to manage conditions related to bowel motility and ammonia accumulation.

- Constipation: softens stools and promotes regular bowel movements. - Hepatic encephalopathy: lowers colonic ammonia absorption, helping improve mental status.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas. - Diarrhea: loose, watery stools. - Nausea: sensation of wanting to vomit. - Stomach cramps: intermittent abdominal pain. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal levels of sodium or potassium. - Dehydration: excessive loss of body fluids. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: persistent, intense pain requiring medical attention.

Before initiating lactulose therapy, consider the following safety measures.

- Renal function assessment: monitor patients with impaired kidney function. - Electrolyte monitoring: watch for hyponatremia or hypokalemia during treatment. - Diabetes caution: observe blood glucose levels as lactulose may affect carbohydrate absorption. - Intestinal obstruction avoidance: contraindicated in patients with known bowel blockage. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Lactulose can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium: may reduce lactulose's osmotic effect. - Stimulant laxatives: increase risk of electrolyte disturbances. - Diuretics: heighten potential for dehydration.

Moderate Interactions (Monitor Closely): - Antibiotics (e.g., rifaximin): may change colonic flora and affect lactulose metabolism. - Oral hypoglycemic agents: monitor glucose control as lactulose can influence carbohydrate handling.